سعر انزاد 1 جم فيال 2025

Inzad 1 g (Rameda > Marcyrl Co.): ceftazidime 1 g powder in a vial for intramuscular or intravenous injection after reconstitution; a parenteral third-generation cephalosporin with antipseudomonal activity.

• Lower respiratory tract infections including pneumonia; skin and skin-structure infections; complicated and uncomplicated urinary tract infections; other serious infections caused by susceptible organisms listed in the label.Population: Adults and pediatric patientsDailyMed (U.S. National Library of Medicine)

• Generally well tolerated; the most common adverse reactions were local reactions after IV injection and allergic and gastrointestinal reactions.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to ceftazidime or to the cephalosporin group of antibacterial drugs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Before therapy, ask about previous hypersensitivity to ceftazidime, cephalosporins, penicillins or other drugs; cross-hypersensitivity among beta-lactams may occur in up to 10% of patients with penicillin allergy; stop the drug if an allergic reaction occurs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Reproduction studies in mice and rats at up to 40 times the human dose showed no impaired fertility or fetal harm, but there are no adequate and well-controlled studies in pregnant women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Ceftazidime is excreted in human milk in low concentrations; use caution in nursing women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Ceftazidime: Parenteral third-generation cephalosporin inhibiting bacterial cell-wall synthesis; notable activity against Pseudomonas aeruginosa.